← Evidence map

ArticleCellular oncology (Dordrecht, Netherlands)2023

Correction: Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity.

Yi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37843798